BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29482123)

  • 1. Therapeutic challenges in comorbid obsessive compulsive disorder with substance use.
    Jain S; Gupta T; Nebhinani N; Singhai K; Suthar N
    Asian J Psychiatr; 2018 Jan; 31():127-128. PubMed ID: 29482123
    [No Abstract]   [Full Text] [Related]  

  • 2. Obsession of pregnancy: Does it exist?
    Faye A; Kirpekar V; Tadke R; Gawande S; Bhave S
    Asian J Psychiatr; 2017 Oct; 29():89-90. PubMed ID: 29061437
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical practice. Obsessive-compulsive disorder.
    Jenike MA
    N Engl J Med; 2004 Jan; 350(3):259-65. PubMed ID: 14724305
    [No Abstract]   [Full Text] [Related]  

  • 4. Naltrexone for the treatment of trichotillomania: a case report.
    Carrion VG
    J Clin Psychopharmacol; 1995 Dec; 15(6):444-5. PubMed ID: 8748437
    [No Abstract]   [Full Text] [Related]  

  • 5. Alcohol binge drinking in OCD: A compulsive ritualistic behaviour to counter magical thinking.
    Dwivedi S; Kar SK
    Asian J Psychiatr; 2017 Oct; 29():160-161. PubMed ID: 29061418
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of CBT with fluoxetine works better for obsessive-compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP
    Asian J Psychiatr; 2012 Mar; 5(1):113. PubMed ID: 26878959
    [No Abstract]   [Full Text] [Related]  

  • 7. Raynaud’s phenomenon in a patient with schizophrenia and obsessive-compulsive disorder: a case report.
    Korkmaz S; Işik U; Korkmaz H
    Turk Psikiyatri Derg; 2011; 22(2):132-3. PubMed ID: 21780344
    [No Abstract]   [Full Text] [Related]  

  • 8. Addition of naltrexone to fluoxetine in the treatment of binge eating disorder.
    Neumeister A; Winkler A; Wöber-Bingöl C
    Am J Psychiatry; 1999 May; 156(5):797. PubMed ID: 10327921
    [No Abstract]   [Full Text] [Related]  

  • 9. Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome.
    Grant JE; Odlaug BL; Potenza MN
    Harv Rev Psychiatry; 2007; 15(2):80-5. PubMed ID: 17454177
    [No Abstract]   [Full Text] [Related]  

  • 10. Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder.
    Leonard HL; Topol D; Bukstein O; Hindmarsh D; Allen AJ; Swedo SE
    J Am Acad Child Adolesc Psychiatry; 1994; 33(6):792-4. PubMed ID: 8083135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological approaches to treatment-resistant obsessive compulsive disorder.
    Goodman WK; McDougle CJ; Barr LC; Aronson SC; Price LH
    J Clin Psychiatry; 1993 Jun; 54 Suppl():16-26. PubMed ID: 8331098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Vortioxetine Monotherapy for an Adolescent With Treatment-Resistant Obsessive-Compulsive Disorder.
    Naguy A; Khraibut B; Al-Khadhari S
    Am J Ther; 2019; 26(6):e797-e799. PubMed ID: 31206363
    [No Abstract]   [Full Text] [Related]  

  • 13. [Obsessive-compulsive symptoms in schizophrenia: remission with anti-obsessive treatment].
    Payá González B; Crespo Facorro B; Sáenz Herrero M; Ayuso Gutiérrez JL
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(3):201-3. PubMed ID: 9717345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The mental disorder and obsessive-compulsive spectrum disorders in childhood ].
    Okada T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):992-8. PubMed ID: 22292193
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychosocial treatment for obsessive-compulsive disorder.
    Munford PR; Hand I; Liberman RP
    Psychiatry; 1994 May; 57(2):142-52. PubMed ID: 7938333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of a relational psychoanalytic approach to dealing with the nonadherent psychiatric patient.
    Lev-Ran S; Nitzan U; Fennig S
    Bull Menninger Clin; 2011 Dec; 75(4):281-94. PubMed ID: 22166127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive treatment of three patients with comorbid OCPD and ADHD.
    Josephson SC; Hollander E; Sumner J
    CNS Spectr; 2007 May; 12(5):338-42. PubMed ID: 17514078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine.
    Kampman M; Keijsers GP; Hoogduin CA; Verbraak MJ
    Acta Psychiatr Scand; 2002 Oct; 106(4):314-9. PubMed ID: 12225499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and management of depression in the context of naltrexone treatment of alcoholism.
    Farren CK; O'Malley SS
    Am J Psychiatry; 1999 Aug; 156(8):1258-62. PubMed ID: 10450269
    [No Abstract]   [Full Text] [Related]  

  • 20. Managing the patient with treatment-resistant obsessive compulsive disorder: current strategies.
    Jenike MA; Rauch SL
    J Clin Psychiatry; 1994 Mar; 55 Suppl():11-7. PubMed ID: 7915709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.